Non-Invasive Imaging Technique Tracks Lung Cancer Cells with High Accuracy

Strategic Insights -

Research conducted at Michigan State University has unveiled a revolutionary non-invasive imaging technique called Magnetic Particle Imaging (MPI), which utilizes superparamagnetic iron oxide nanoparticles to track the distribution, survival, and integration of transplanted cells in the lungs of immunocompromised mice. This groundbreaking method offers a potential solution for monitoring cell therapy in pulmonary fibrosis, a progressive and chronic lung disease characterized by scarring and impaired gas exchange. The study demonstrates the effectiveness of MPI in visualizing cell integration and retention within lung tissue, with a 65% decrease in signal overtime.

Key Takeaways:

  • Pulmonary fibrosis is a progressive and chronic lung disease affecting approximately 50,000 new patients annually in the United States, with no cure available.
  • Current therapeutic options for pulmonary fibrosis are limited in efficacy and focus on slowing disease progression, with cell therapy emerging as a promising intervention.
  • MPI is a novel, non-invasive imaging modality utilizing superparamagnetic iron oxide nanoparticles that offers high sensitivity, specificity, and real-time tracking of labeled cells in vivo.
  • The study demonstrates the utility of MPI for non-invasive, longitudinal tracking of cell therapy in pulmonary fibrosis, with successful instillation exhibiting MPI signals in both lungs, which decreased overtime.
  • Longitudinal imaging over 2 weeks enabled visualization of cell integration and retention within lung tissue, with 65% signal decrease overtime.
  • Researchers at Michigan State University optimized the MPI signal by labeling cells with varying superparamagnetic iron oxide nanoparticle concentrations, confirmed by immunostaining and iron quantification.
  • The study was conducted by Ping Wang, Saumya Nigam, Manvir Bamrah, Elizabeth Kenyon, Katie Uhl, Xiaopeng Li, Chris Lin, Tara E. Jager, Cameron Lawson, Reda E. Girgis, and Jinxing Li, with contact information located at Michigan State University and the Precis Hlth Program.

Statistics:

  • Approximately 50,000 new cases of pulmonary fibrosis are reported annually in the United States.
  • Current therapeutic options for pulmonary fibrosis are limited in efficacy, primarily focusing on slowing disease progression.
  • 65% decrease in MPI signal overtime, indicating successful cell integration and retention within lung tissue.
  • Longitudinal imaging over 2 weeks enabled visualization of cell integration and retention within lung tissue.

Sources:

  • [Source 1] NewsRx. Reports Outline Lung Cancer Study Findings from Michigan State University (Image-guided in Vivo Tracking of Transplanted Distal Lung Epithelial Progenitor Cells for Pulmonary Fibrosis Using Magnetic Particle Imaging). Cancer Weekly. August 12, 2025; p 1286.
  • [Source 2] Journal of Visualized Experiments. Image-guided in Vivo Tracking of Transplanted Distal Lung Epithelial Progenitor Cells for Pulmonary Fibrosis Using Magnetic Particle Imaging. Journal of Visualized Experiments, 2025(220).
  • [Source 3] Journal of Visualized Experiments. Contact information: Journal of Visualized Experiments, 1 Alewife Center, Ste 200, Cambridge, MA 02140, USA.
  • [Source 4] Michigan State University. Contact information: Ping Wang, Precis Hlth Program, East Lansing, MI 48824, United States.